| Literature DB >> 35011850 |
Gian Eugenio Tontini1,2, Giovanni Aldinio1,2, Nicoletta Nandi1,2, Alessandro Rimondi1,2, Dario Consonni3, Massimo Iavarone4, Paolo Cantù2, Angelo Sangiovanni4, Pietro Lampertico2,4, Maurizio Vecchi1,2.
Abstract
BACKGROUND: COVID-19 pandemic has profoundly changed the activities and daily clinical scenarios, subverting organizational requirements of our Gastroenterology Units. AIM: to evaluate the clinical needs and outcomes of the gastroenterological ward metamorphosis during the COVID-19 outbreaks in a high incidence scenario.Entities:
Keywords: COVID-19; SARS-CoV-2; delivery of healthcare; endoscopy; gastroenterology; hepatology
Year: 2021 PMID: 35011850 PMCID: PMC8745083 DOI: 10.3390/jcm11010109
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Study population.
| Pre-COVID ( | First Wave ( | Transition ( | Second Wave ( | ||||
|---|---|---|---|---|---|---|---|
| Outcome | No. (%) of Patients | No. (%) of Patients | Prevalence Ratio(95% CI) | No. (%) of Patients | Prevalence Ratio (95% CI) | No. (%) of Patients | Prevalence Ratio (95% CI) |
| Sex | |||||||
| Female | 72 (34.5) | 70 (40.7) | 32 (37.7) | 99 (42.5) | |||
| Male | 157 (65.5) | 102 (59.3) | 0.90 (0.77 to 1.06) | 53 (62.3) | 0.95 (0.78 to 1.15) | 134 (57.5) | 0.88 (0.76 to 1.02) |
| Pertinent GE diagnoses | 201 (96.2) | 75 (43.6) | 0.45 (0.38 to 0.54) | 79 (92.9) | 0.97 (0.91 to 1.03) | 199 (85.4) | 0.89 (0.84 to 0.94) |
| Admissions from domicile | 124 (59.3) | 27 (15.7) | 0.26 (0.18 to 0.38) | 38 (44.7) | 0.75 (0.58 to 0.98) | 95 (40.8) | 0.69 (0.57 to 0.83) |
| Mortality | 1 (0.5) | 7 (4.1) | 8.51 (1.06 to 68.5) | 3 (3.5) | 7.38 (0.78 to 69.9) | 13 (5.6) | 11.66 (1.54 to 88.4) |
| Patients undergoing ≥ 1 | |||||||
| endoscopic procedure | 98 (46.9) | 31 (18.0) | 0.38 (0.27 to 0.55) | 44 (51.8) | 1.10 (0.86 to 1.42) | 96 (41.2) | 0.88 (0.71 to 1.08) |
| IR procedure | 69 (33.0) | 26 (15.1) | 0.46 (0.31 to 0.69) | 29 (34.1) | 1.03 (0.73 to 1.47) | 67 (28.8) | 0.87 (0.66 to 1.15) |
Figure 1Daily incidence of SARS-CoV-2 during the first wave (SARS-CoV-2 molecular nasopharyngeal swab positive tests).
Figure 2Proportions of pertinent gastroenterological discharge diagnoses.
Length of stay and Charlson comorbidity index.
| Pre-COVID ( | First Wave ( | Transition ( | Second Wave ( | Total |
| |
|---|---|---|---|---|---|---|
| Outcome | Median (Range) | Median (Range) | Median (Range) | Median (Range) | Median (Range) | |
| Age (years) | 65.0 (22.5 to 92.2) | 73.0 (18.8 to 98.9) | 64.0 (17.0 to 88.0) | 69.0 (18.5 to 96.0) | 68.0 (17.0 to 98.9) | <0.001 |
| Length of stay (days) | 4.0 (0.0 to 201.0) | 5.5 (0.0 to 40.0) | 7.0 (1.0 to 61.0) | 6.0 (0.0 to 52.0) | 5.0 (0.0 to 201.0) | 0.001 |
| Charlson comorbidity index | 5.0 (0.0 to 12.0) | 6.0 (0.0 to 16.0) | 5.0 (0.0 to 11.0) | 5.0 (0.0 to 11.0) | 5.0 (0.0 to 16.0) | 0.02 |